Brain metastasis risk in non-small cell lung cancer
Part of Brain & nervous system, Cancer, Lungs & breathing clinical trials.
This study looks at how often brain metastasis happens in people with non-small cell lung cancer and how it affects their outlook. By following participants who receive standard treatment, researchers hope to learn more about the risks and outcome.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with non-small cell lung cancer.
- You are 18 years old or older.
- You are in good physical condition (able to care for yourself and do daily tasks).
- You have had a complete brain MRI with contrast before starting cancer treatment.
- You are receiving standard treatment for your lung cancer.
- You do not have other active cancers (except cured early skin or cervical cancer).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether some people with brain metastases from solid tumors can safely skip radiation if their cancer drugs (like targeted therapy, immunotherapy, or certain chemotherapies) shrink the brain tumors. You will get MRI scans to see if the drugs are working.
This study uses advanced computer models to predict how likely lung cancer is to spread to the brain and how it may affect your health. It includes people with lung cancer who are getting standard treatment and have had recent MRI and CT scans.
This trial tests a combination of radiation to the brain plus chemotherapy and immunotherapy (anti-PD-1/PD-L1) for people with newly diagnosed non-small cell lung cancer that has spread to the brain. It is for those whose tumors do not have common driver mutations and whose brain metastases are causing symptoms.
This trial looks at people with non-small cell lung cancer that has spread to the brain or the membranes around the brain. It aims to learn more about patients who are already scheduled for brain surgery, such as removing a tumor or placing a drain.
This study looks at how people with non-small cell lung cancer that has spread to the lining of the brain or spinal cord are treated in real-world clinics in China. If you have received treatment for this spread since 2018, you may be able to help doctors learn what works best.
This trial tests whether combining brain radiation with chemotherapy and immunotherapy can help people with advanced lung cancer that has spread to the brain but has not yet been treated. It is for those whose tumors do not have certain gene mutations (EGFR, ALK, ROS1).
Hear when a new Brain Metastases From Non-small Cell Lung Cancer (NSCLC) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.